Landry K. Kamdem
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: St. Jude Children's Research Hospital (2008); Johannes Gutenberg University Mainz (2006); Central Hospital of Yaoundé (2014); Indiana University School of Medicine (2010); Indiana University – Purdue University Indianapolis (2010–2011); University of Göttingen (2004–2006)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Landry K. Kamdem's research focuses on factors influencing endocrine therapy adherence in breast cancer patients. His work has investigated the relative contributions of drug-related and patient-related elements to treatment adherence. Kamdem has published 26 scholarly works, which have garnered over 1,184 citations, and maintains an h-index of 14. He has collaborated with Sophia Tilley, Mariam F Haji-Hersi, and Caleb A Shelton, all from Harding University Main Campus, on shared publications.
Metrics
- h-index: 14
- Publications: 26
- Citations: 1,185
Selected Publications
-
Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients (2021)
-
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion (2019)PMC OpenAlex
-
Effect of Aromatase Inhibition (Exemestane) on Urine Concentration of Osteoprotegerin in Healthy Postmenopausal Women (2019)
-
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion (2019)
-
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium (2018)
-
Impact of the <i>OATP1B1</i> c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers (2017)
-
COX2 induction: a mechanism of endocrine breast cancer resistance? (2017)
-
Impact of<i>UGT2B17</i>Gene Deletion on the Pharmacokinetics of 17-Hydroexemestane in Healthy Volunteers (2015)
-
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia (2015)
Collaboration Network
Top Collaborators
- Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients
- Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients
- Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients
- Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients
Similar Researchers
Based on overlapping research topics